Product Development Pipeline

Our innovative approach to drug development has resulted in multiple drug candidates progressing in clinical development that offer significant new promise to patient populations that currently have no or limited treatment options. Each novel, differentiated drug candidate is the result of application of our proprietary RAMP drug innovation engine to the same clinically validated kinase target.

Back to Top